Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Labomics is a Belgian life sciences company that specializes in the distribution of high-quality reagents and the provision of specialized laboratory services. The company supports research in molecular biology, cell biology, immunology, and proteomics by offering a wide range of products including antibodies, assay kits, and genomic tools. In addition to product distribution, Labomics provides contract research services such as Next-Generation Sequencing (NGS), bioinformatics, and protein analysis. They serve academic institutions, biotech companies, and pharmaceutical laboratories across Europe, focusing on accelerating scientific discovery through technical expertise and premium laboratory solutions. By acting as a bridge between innovative global manufacturers and the local research community, Labomics ensures access to cutting-edge tools for drug discovery and basic research.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Labomics.